Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Paclitaxel by DAE HWA Pharmaceutical for Metastatic Breast Cancer: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase II for Metastatic Breast Cancer. According to...
Data Insights
Paclitaxel by DAE HWA Pharmaceutical for Metastatic Breast Cancer: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase II for Metastatic Breast Cancer. According to...